Association of the transthyretin variant V122I with polyneuropathy among individuals of African descent
Margaret M. Parker, Scott M. Damrauer, Catherine Tcheandjieu, David Erbe, Emre Aldinc, Philip N. Hawkins, Julian D. Gillmore, Leland E. Hull, Julie A. Lynch, Jacob Joseph, Simina Ticau, Alexander O. Flynn-Carroll, Aimee M. Deaton, View ORCID ProfileLucas D. Ward, Themistocles L. Assimes, Philip S. Tsao, View ORCID ProfileKyong-Mi Chang, Daniel J. Rader, Kevin Fitzgerald, Akshay K. Vaishnaw, Gregory Hinkle, Paul Nioi
doi: https://doi.org/10.1101/2020.11.10.20219675
Margaret M. Parker
1Alnylam Pharmaceuticals, Cambridge, USA
Scott M. Damrauer
2Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
3The Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA
Catherine Tcheandjieu
412 VA Palo Alto Health Care System, Palo Alto, CA, USA
5Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
David Erbe
1Alnylam Pharmaceuticals, Cambridge, USA
Emre Aldinc
1Alnylam Pharmaceuticals, Cambridge, USA
Philip N. Hawkins
6Centre for Amyloidosis & Acute Phase Proteins, Division of Medicine UCL (Royal Free Campus), London, UK
Julian D. Gillmore
6Centre for Amyloidosis & Acute Phase Proteins, Division of Medicine UCL (Royal Free Campus), London, UK
Leland E. Hull
7Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
8Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, USA
Julie A. Lynch
9School of Nursing & Health Sciences, University of Massachusetts, Boston, MA, USA
10VA Informatics and Computing Infrastructure (VINCI), VA Salt Lake City Health Care System, Salt Lake City, UT, USA
Jacob Joseph
11Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, MA, USA
12Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Simina Ticau
1Alnylam Pharmaceuticals, Cambridge, USA
Alexander O. Flynn-Carroll
1Alnylam Pharmaceuticals, Cambridge, USA
Aimee M. Deaton
1Alnylam Pharmaceuticals, Cambridge, USA
Lucas D. Ward
1Alnylam Pharmaceuticals, Cambridge, USA
Themistocles L. Assimes
412 VA Palo Alto Health Care System, Palo Alto, CA, USA
5Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Philip S. Tsao
412 VA Palo Alto Health Care System, Palo Alto, CA, USA
5Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Kyong-Mi Chang
3The Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA
13Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Daniel J. Rader
13Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
14Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Kevin Fitzgerald
1Alnylam Pharmaceuticals, Cambridge, USA
Akshay K. Vaishnaw
1Alnylam Pharmaceuticals, Cambridge, USA
Gregory Hinkle
1Alnylam Pharmaceuticals, Cambridge, USA
Paul Nioi
1Alnylam Pharmaceuticals, Cambridge, USA

Data Availability
UK Biobank data is available upon application to the UK Biobank.
Posted February 08, 2021.
Association of the transthyretin variant V122I with polyneuropathy among individuals of African descent
Margaret M. Parker, Scott M. Damrauer, Catherine Tcheandjieu, David Erbe, Emre Aldinc, Philip N. Hawkins, Julian D. Gillmore, Leland E. Hull, Julie A. Lynch, Jacob Joseph, Simina Ticau, Alexander O. Flynn-Carroll, Aimee M. Deaton, Lucas D. Ward, Themistocles L. Assimes, Philip S. Tsao, Kyong-Mi Chang, Daniel J. Rader, Kevin Fitzgerald, Akshay K. Vaishnaw, Gregory Hinkle, Paul Nioi
medRxiv 2020.11.10.20219675; doi: https://doi.org/10.1101/2020.11.10.20219675
Association of the transthyretin variant V122I with polyneuropathy among individuals of African descent
Margaret M. Parker, Scott M. Damrauer, Catherine Tcheandjieu, David Erbe, Emre Aldinc, Philip N. Hawkins, Julian D. Gillmore, Leland E. Hull, Julie A. Lynch, Jacob Joseph, Simina Ticau, Alexander O. Flynn-Carroll, Aimee M. Deaton, Lucas D. Ward, Themistocles L. Assimes, Philip S. Tsao, Kyong-Mi Chang, Daniel J. Rader, Kevin Fitzgerald, Akshay K. Vaishnaw, Gregory Hinkle, Paul Nioi
medRxiv 2020.11.10.20219675; doi: https://doi.org/10.1101/2020.11.10.20219675
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)